CGON
Price
$25.69
Change
-$0.27 (-1.04%)
Updated
Aug 15, 04:59 PM (EDT)
Capitalization
1.96B
RVMD
Price
$36.30
Change
+$0.28 (+0.78%)
Updated
Aug 15, 04:59 PM (EDT)
Capitalization
6.79B
81 days until earnings call
Interact to see
Advertisement

CGON vs RVMD

Header iconCGON vs RVMD Comparison
Open Charts CGON vs RVMDBanner chart's image
CG Oncology
Price$25.69
Change-$0.27 (-1.04%)
Volume$5.8K
Capitalization1.96B
Revolution Medicines
Price$36.30
Change+$0.28 (+0.78%)
Volume$12.98K
Capitalization6.79B
CGON vs RVMD Comparison Chart in %
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. RVMD commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and RVMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (CGON: $25.70 vs. RVMD: $36.32)
Brand notoriety: CGON and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 45% vs. RVMD: 51%
Market capitalization -- CGON: $1.96B vs. RVMD: $6.79B
CGON [@Biotechnology] is valued at $1.96B. RVMD’s [@Biotechnology] market capitalization is $6.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, CGON is a better buy in the long-term than RVMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 3 TA indicator(s) are bullish while RVMD’s TA Score has 3 bullish TA indicator(s).

  • CGON’s TA Score: 3 bullish, 5 bearish.
  • RVMD’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, RVMD is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а +3.42% price change this week, while RVMD (@Biotechnology) price change was +3.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

RVMD is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($6.79B) has a higher market cap than CGON($1.96B). CGON YTD gains are higher at: -10.391 vs. RVMD (-16.964). CGON has higher annual earnings (EBITDA): -134.35M vs. RVMD (-776.65M). RVMD has more cash in the bank: 2.1B vs. CGON (688M). CGON has less debt than RVMD: CGON (1.04M) vs RVMD (134M). CGON has higher revenues than RVMD: CGON (662K) vs RVMD (0).
CGONRVMDCGON / RVMD
Capitalization1.96B6.79B29%
EBITDA-134.35M-776.65M17%
Gain YTD-10.391-16.96461%
P/E RatioN/AN/A-
Revenue662K0-
Total Cash688M2.1B33%
Total Debt1.04M134M1%
TECHNICAL ANALYSIS
Technical Analysis
CGONRVMD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 9 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RTXCX12.760.10
+0.79%
Russell Inv Tax-Managed Real Assets C
CVFYX16.38N/A
N/A
Victory Pioneer Disciplined Value Y
CAIBX78.02N/A
N/A
American Funds Capital Income Bldr A
SMNAX26.16N/A
N/A
Steward Equity Market Neutral A
DUSLX42.01-0.07
-0.17%
DFA US Large Cap Growth Instl

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-1.00%
IDYA - CGON
61%
Loosely correlated
-0.16%
SYRE - CGON
61%
Loosely correlated
+0.53%
ACLX - CGON
57%
Loosely correlated
+3.09%
KYMR - CGON
55%
Loosely correlated
+2.60%
NUVL - CGON
55%
Loosely correlated
-0.99%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with CRNX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+0.83%
CRNX - RVMD
56%
Loosely correlated
+3.47%
OCUL - RVMD
55%
Loosely correlated
-0.24%
ERAS - RVMD
52%
Loosely correlated
+4.46%
CGON - RVMD
52%
Loosely correlated
-1.00%
NRIX - RVMD
52%
Loosely correlated
+0.19%
More